Global Mesenchymal Stem Cells Market Size & Outlook
Global mesenchymal stem cells market, 2018-2030 (US$M)
Related Markets
Global mesenchymal stem cells market highlights
- The global mesenchymal stem cells market generated a revenue of USD 3,124.1 million in 2023 and is expected to reach USD 7,266.4 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 12.8% by 2030.
- In terms of segment, product accounted for a revenue of USD 2,464.5 million in 2023.
- Services is the most lucrative product & services segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 3,124.1 million |
| Market revenue in 2030 | USD 7,266.4 million |
| Growth rate | 12.8% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Services |
Other key industry trends
- In terms of revenue, the North America accounted for 45.1% of the global mesenchymal stem cells market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Kuwait is the fastest growing regional market and is projected to reach USD 1.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Mesenchymal Stem Cells Market Scope
Mesenchymal Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global mesenchymal stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mesenchymal stem cells market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 78.89% in 2023. Horizon Databook has segmented the Global mesenchymal stem cells market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
Growing The strong pipeline of MSC-based products is recognized as a major driving force for the global mesenchymal stem cell market. For instance, in 2022, the U.S.FDA has approved around 19 stem cell therapies for range of life-threatening disorders. Some of these therapies include, BREYANZI of BMS, ALLOCORD, KYMIRAH of Novartis etc.
Furthermore, the number of clinical trials based on MSCs has increased significantly since 2008. According to a study published in July 2020, the number of clinical trials registered at the U.S. FDA that are exploring potential of mesenchymal stem cells has exceeded 1,050.
The number of companies that have or are in process of commercializing MSC-based therapies is increasing. For instance, Takeda/TiGenix phase 3 clinical trial incorporates MSCs for complex perianal fistulas in Crohn's disease. This was the most successful late-stage clinical trial, as of September 2020.
Reasons to subscribe to Global mesenchymal stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global mesenchymal stem cells market databook
-
Our clientele includes a mix of mesenchymal stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global mesenchymal stem cells market , including forecasts for subscribers. This global databook contains high-level insights into Global mesenchymal stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global mesenchymal stem cells market size, by regions, 2018-2030 (US$M)
Top 10 countries: Mesenchymal stem cells market size, 2023 (US$M)
Global mesenchymal stem cells market share, by product & services, 2023 & 2030 (%, US$M)
Mesenchymal stem cells market: Opportunity assessment by country
Global mesenchymal stem cells market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
